These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8064897)

  • 1. Financial concerns prompt sponsoring pharmaceutical company to halt international phase I studies.
    Stoter G; Arnold AA; Kurzrock R; Rustin GJ
    J Natl Cancer Inst; 1994 Sep; 86(17):1353. PubMed ID: 8064897
    [No Abstract]   [Full Text] [Related]  

  • 2. Inside information: Financial conflicts of interest for research subjects in early phase clinical trials.
    Helft PR; Ratain MJ; Epstein RA; Siegler M
    J Natl Cancer Inst; 2004 May; 96(9):656-61. PubMed ID: 15126602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infants, science may lose as liability is blamed for company pullout from HIV prevention trial.
    Cotton P
    JAMA; 1992 Oct; 268(15):1987, 1991-2. PubMed ID: 1404725
    [No Abstract]   [Full Text] [Related]  

  • 4. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creating a global health care company.
    Bauman RP
    J Bus Strategy; 1992; 13(2):4-7. PubMed ID: 10117143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. India remains on US trade "priority watch list" for failing to uphold international drug company patents.
    Arie S
    BMJ; 2013 May; 346():f2949. PubMed ID: 23657189
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials regulation--how Canada compares.
    Shuchman M
    CMAJ; 2008 Sep; 179(7):635-8. PubMed ID: 18809888
    [No Abstract]   [Full Text] [Related]  

  • 8. The North American Free Trade Agreement's effect on pharmaceutical patents: a bitter pill to swallow or a therapeutic solution?
    Silbermann JM
    J Contemp Health Law Policy; 1996; 12(2):607-36. PubMed ID: 8666736
    [No Abstract]   [Full Text] [Related]  

  • 9. Economic and policy implications of reimportation: a Canadian perspective.
    Ward C
    Manag Care; 2004 Mar; 13(3 Suppl):17-20. PubMed ID: 15074165
    [No Abstract]   [Full Text] [Related]  

  • 10. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
    Ghosh S
    Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
    [No Abstract]   [Full Text] [Related]  

  • 11. Getting it right: industry sponsorship and medical research.
    Baird P
    CMAJ; 2003 May; 168(10):1267-9. PubMed ID: 12743071
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceutical arbitrage: balancing access and innovation in international prescription drug markets.
    Outterson K
    Yale J Health Policy Law Ethics; 2005; 5(1):193-291. PubMed ID: 15742578
    [No Abstract]   [Full Text] [Related]  

  • 13. Patent nonsense: evidence tells of an industry out of social control.
    Mintzberg H
    CMAJ; 2006 Aug; 175(4):374. PubMed ID: 16908900
    [No Abstract]   [Full Text] [Related]  

  • 14. International diversification and US regulatory controls in the pharmaceutical industry.
    Goedde AG
    Q Rev Econ Bus; 1982; 22(1):101-10. PubMed ID: 10317195
    [No Abstract]   [Full Text] [Related]  

  • 15. CancerScope. Clinical trials go global. As trial recruitment expands worldwide, fewer US patients take part.
    Printz C
    Cancer; 2009 Mar; 115(6):1135-7. PubMed ID: 19260035
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of drug reimportation on managed care pharmacy.
    Penna P
    Manag Care Interface; 2003 Jul; 16(7):41-2. PubMed ID: 12908216
    [No Abstract]   [Full Text] [Related]  

  • 17. Inquiries in Britain uncover loopholes in drug trials.
    Rosenthal E
    N Y Times Web; 2006 Aug; ():A3. PubMed ID: 16909495
    [No Abstract]   [Full Text] [Related]  

  • 18. Remarks delivered at the Food and Drug Law Institute's 48th Annual Conference.
    Enzi MB
    Food Drug Law J; 2005; 60(2):103-6. PubMed ID: 16097090
    [No Abstract]   [Full Text] [Related]  

  • 19. Australia-United States Free Trade Agreement and the Australian Pharmaceutical Benefits Scheme.
    Sainsbury P
    Yale J Health Policy Law Ethics; 2004; 4(2):387-99. PubMed ID: 15536920
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulatory expectation for data on viral testing and process evaluation for phase I studies and product licensing in the United States, Europe and Japan.
    Ridgway A
    Dev Biol Stand; 1996; 88():141-2. PubMed ID: 9119126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.